LINC01315 and nasopharyngeal carcinoma: LINC01315 has been reported to be upregulated in nasopharyngeal carcinoma [21] and colorectal carcinoma (CRC), and it may be a prognostic biomarker in triple-negative breast cancer (TNBC) [22].